Výsledky vyhľadávania - "Hand-Foot Syndrome etiology"

Evaluation of patient-reported severity of hand–foot syndrome under capecitabine using a Markov modeling approach

Autori: Eduard Schmulenson Linda Krolop Sven Simons a ďalší

Zdroj: Cancer Chemother Pharmacol

Predmety: Adult, Aged, 80 and over, Male, Antimetabolites, Antineoplastic, Middle Aged, Prognosis, Markov Chains, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Female [MeSH], Follow-Up Studies [MeSH], Patient-reported outcomes, Aged, 80 and over [MeSH], Aged [MeSH], Adult [MeSH], Antimetabolites, Antineoplastic/adverse effects [MeSH], Humans [MeSH], Prospective Studies [MeSH], Middle Aged [MeSH], Capecitabine, Hand-Foot Syndrome/etiology [MeSH], Patient Reported Outcome Measures [MeSH], Original Article, Hand–foot syndrome, Male [MeSH], Neoplasms/pathology [MeSH], Markov Chains [MeSH], Neoplasms/drug therapy [MeSH], Prognosis [MeSH], Hand-Foot Syndrome/pathology [MeSH], Markov model, Capecitabine/adverse effects [MeSH], Neoplasms, Humans, Female, Hand-Foot Syndrome, Patient Reported Outcome Measures, Prospective Studies, 10. No inequality, Aged, Follow-Up Studies

Prístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s00280-020-04128-7.pdf
https://pubmed.ncbi.nlm.nih.gov/32852627
https://link.springer.com/article/10.1007/s00280-020-04128-7
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478943
https://pubmed.ncbi.nlm.nih.gov/32852627/
https://link.springer.com/content/pdf/10.1007/s00280-020-04128-7.pdf
https://repository.publisso.de/resource/frl:6467042

Hepatic arterial therapy with oxaliplatin and systemic capecitabine for patients with liver metastases from breast cancer

Autori: Lindgaard, S C Brinch, C M Jensen, B K a ďalší

Zdroj: The Breast. 43:113-119

Predmety: Adult, Breast Neoplasms/pathology, Peripheral Nervous System Diseases/chemically induced, Breast Neoplasms, Adenocarcinoma, 03 medical and health sciences, Oxaliplatin/administration & dosage, Hepatic Artery, 0302 clinical medicine, Adenocarcinoma/secondary, Antineoplastic Combined Chemotherapy Protocols, Humans, Chemoembolization, Therapeutic, Capecitabine, Fatigue, Aged, Liver Neoplasms, Peripheral Nervous System Diseases, Middle Aged, Progression-Free Survival, Abdominal Pain, 3. Good health, Oxaliplatin, Hand-Foot Syndrome/etiology, Capecitabine/administration & dosage, Liver Neoplasms/secondary, Fatigue/chemically induced, Abdominal Pain/chemically induced, Chemoembolization, Female, Hand-Foot Syndrome, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Therapeutic/methods

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/30544058
https://pubmed.ncbi.nlm.nih.gov/30544058/
https://lup.lub.lu.se/search/publication/73456083-6f40-4c9f-a4b8-4be9081c07c9
https://www.sciencedirect.com/science/article/pii/S096097761830331X
https://www.ncbi.nlm.nih.gov/pubmed/30544058
https://europepmc.org/abstract/MED/30544058
https://portal.research.lu.se/en/publications/hepatic-arterial-therapy-with-oxaliplatin-and-systemic-capecitabi

Efficacy and safety of regorafenib in the treatment of metastatic colorectal cancer: A systematic review

Autori: Maria Røed Skårderud Anne Polk Kirsten Kjeldgaard Vistisen a ďalší

Zdroj: Cancer Treatment Reviews. 62:61-73

Predmety: Pyridines, Hypertension/chemically induced, Phenylurea Compounds, Antineoplastic Agents/therapeutic use, Colorectal Neoplasms/drug therapy, Antineoplastic Agents, Disease-Free Survival, 3. Good health, Phase III as Topic, Survival Rate, 03 medical and health sciences, 0302 clinical medicine, Hand-Foot Syndrome/etiology, Clinical Trials, Phase III as Topic, Fatigue/chemically induced, Hypertension, Humans, Clinical Trials, Hand-Foot Syndrome, Neoplasm Metastasis, Colorectal Neoplasms, Pyridines/therapeutic use, Fatigue, Phenylurea Compounds/therapeutic use, Proportional Hazards Models

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/29175677
https://europepmc.org/article/MED/29175677
https://www.sciencedirect.com/science/article/pii/S0305737217301810
https://pubmed.ncbi.nlm.nih.gov/29175677/
https://www.ncbi.nlm.nih.gov/pubmed/29175677

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy

Autori: Hiroji Iwata Shinji Ohno Shoichiro Ohtani a ďalší

Prispievatelia: Hiroji Iwata Shinji Ohno Shoichiro Ohtani a ďalší

Zdroj: New England Journal of Medicine. 376:2147-2159

Predmety: Adult, Antimetabolites, Antineoplastic, Antimetabolites, Triple Negative Breast Neoplasms/drug therapy, Receptor, ErbB-2, Breast Neoplasms/surgery, Triple Negative Breast Neoplasms/mortality, Breast Neoplasms/mortality, Breast Neoplasms, Triple Negative Breast Neoplasms, Antineoplastic/therapeutic use, Antineoplastic/adverse effects, 03 medical and health sciences, ErbB-2, 0302 clinical medicine, Breast Neoplasms/drug therapy, Preoperative Care, Chemotherapy, Humans, Adjuvant/adverse effects, Capecitabine, Aged, Neoplasm Staging, Capecitabine/therapeutic use, Capecitabine/adverse effects, Middle Aged, Survival Analysis, Neoadjuvant Therapy, 3. Good health, Hand-Foot Syndrome/etiology, Chemotherapy, Adjuvant, Female, Hand-Foot Syndrome, Receptor

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/28564564
https://tohoku.pure.elsevier.com/en/publications/adjuvant-capecitabine-for-breast-cancer-after-preoperative-chemot
https://koreauniv.pure.elsevier.com/en/publications/adjuvant-capecitabine-for-breast-cancer-after-preoperative-chemot
https://www.nejm.org/doi/full/10.1056/NEJMoa1612645
https://ir.ymlib.yonsei.ac.kr/bitstream/22282913/160344/1/T201702154.pdf
https://mdanderson.elsevierpure.com/en/publications/adjuvant-capecitabine-for-breast-cancer-after-preoperative-chemot
https://www.ncbi.nlm.nih.gov/pubmed/28564564

REGOSARC: Regorafenib versus placebo in doxorubicin‐refractory soft‐tissue sarcoma—A quality‐adjusted time without symptoms of progression or toxicity analysis

Autori: Berry, Vincent Basson, Laurent Bogart, Emilie a ďalší

Prispievatelia: Berry, Vincent Basson, Laurent Bogart, Emilie a ďalší

Zdroj: Cancer

Predmety: Leiomyosarcoma, Male, [SDV]Life Sciences [q-bio], Mesh:Diarrhea/chemically induced, 0302 clinical medicine, Mesh:Alopecia/chemically induced, Mesh:Phenylurea Compounds/therapeutic use, Mesh:Aged, Mesh:Synovial/drug therapy, Mesh:Treatment Outcome, Mesh:Anorexia/chemically induced, Liposarcoma, Middle Aged, 16. Peace & justice, Anorexia, 3. Good health, [SDV] Life Sciences [q-bio], Hospitalization, Mesh:Quality of Life, Hypertension, Female, Hand-Foot Syndrome, Mesh:Proportional Hazards Models, Mesh:Severity of Illness Index, Mesh:Female, Diarrhea, Mucositis, quality-adjusted survival, Mesh:Fecal Incontinence/chemically induced, Mesh:Male, Antineoplastic Agents, Mesh:Sarcoma, 03 medical and health sciences, Double-Blind Method, quality-adjusted time without symptoms of progression or toxicity (Q-TWiST), Mesh:Middle Aged, Mesh:Asthenia/chemically induced, Mesh:Liposarcoma/drug therapy, Humans, metastatic soft-tissue sarcoma, placebo, regorafenib, Mesh:Hospitalization, Mesh:Mucositis/chemically induced, Mesh:Sarcoma/drug therapy, Mesh:Hand-Foot Syndrome/etiology, Aged, Proportional Hazards Models, Mesh:Pyridines/therapeutic use, Phenylurea Compounds, Mesh:Antineoplastic Agents/therapeutic use, Alopecia, Original Articles, Mesh:Leiomyosarcoma/drug therapy, Mesh:Humans, Asthenia, Mesh:Hypertension/chemically induced, Fecal Incontinence, Mesh:Double-Blind Method

Popis súboru: application/octet-stream; application/rdf+xml; charset=utf-8; application/pdf

Prístupová URL adresa: https://acsjournals.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.30661
https://pubmed.ncbi.nlm.nih.gov/28295221
https://acsjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.30661
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485075
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.30661
https://europepmc.org/articles/PMC5485075
https://pubmed.ncbi.nlm.nih.gov/28295221/
https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.30661
http://hdl.handle.net/20.500.12210/17207
https://hal.univ-lille.fr/hal-02638646v1
https://doi.org/10.1002/cncr.30661
https://hal.univ-lille.fr/hal-02638646v1/document

Effect of urea cream on sorafenib-associated hand-foot skin reaction in patients with hepatocellular carcinoma: A multicenter, randomised, double-blind controlled study

Prispievatelia: Young-Sun Lee Young K Jung Ji H Kim a ďalší

Predmety: Aged, Antineoplastic Agents / adverse effects, Antineoplastic Agents / therapeutic use, Carcinoma, Hepatocellular / drug therapy, Double-Blind Method, Female, Hand-Foot Syndrome / drug therapy, Hand-Foot Syndrome / etiology, Humans, Liver Neoplasms / drug therapy, Male, Middle Aged, Quality of Life, Skin / drug effects, Skin Cream / therapeutic use, Skin Diseases / chemically induced, Skin Diseases / drug therapy, Sorafenib / adverse effects, Sorafenib / therapeutic use, Urea / therapeutic use, Hand–foot skin reaction, Hepatocellular carcinoma, Urea cream

Relation: EUROPEAN JOURNAL OF CANCER; J00809; https://ir.ymlib.yonsei.ac.kr/handle/22282913/183840; https://www.sciencedirect.com/science/article/pii/S0959804920305189; T202007145

Dostupnosť: https://ir.ymlib.yonsei.ac.kr/handle/22282913/183840
https://doi.org/10.1016/j.ejca.2020.09.012
https://www.sciencedirect.com/science/article/pii/S0959804920305189

Regosarc: regorafenib versus placebo in doxorubicin-refractory soft-tissue sarcoma-a quality-adjusted time without symptoms of progression or toxicity analysis

Autori: Berry, Vincent Basson, Laurent Bogart, Emilie a ďalší

Prispievatelia: Berry, Vincent Basson, Laurent Bogart, Emilie a ďalší

Predmety: quality-adjusted time without symptoms of progression or toxicity (Q-TWiST), metastatic soft-tissue sarcoma, placebo, quality-adjusted survival, regorafenib, Mesh:Hypertension/chemically induced, Mesh:Liposarcoma/drug therapy, Mesh:Treatment Outcome, Mesh:Severity of Illness Index, Mesh:Sarcoma, Mesh:Synovial/drug therapy, Mesh:Sarcoma/drug therapy, Mesh:Quality of Life, Mesh:Male, Mesh:Middle Aged, Mesh:Mucositis/chemically induced, Mesh:Phenylurea Compounds/therapeutic use, Mesh:Proportional Hazards Models, Mesh:Pyridines/therapeutic use, Mesh:Leiomyosarcoma/drug therapy, Mesh:Aged, Mesh:Alopecia/chemically induced, Mesh:Anorexia/chemically induced, Mesh:Antineoplastic Agents/therapeutic use, Mesh:Asthenia/chemically induced, Mesh:Diarrhea/chemically induced, Mesh:Double-Blind Method, Mesh:Fecal Incontinence/chemically induced, Mesh:Female, Mesh:Hand-Foot Syndrome/etiology

Popis súboru: application/octet-stream; application/rdf+xml; charset=utf-8; application/pdf

Relation: Cancer; http://hdl.handle.net/20.500.12210/17207

Dostupnosť: https://hdl.handle.net/20.500.12210/17207

Risk factors and model for predicting toxicity‐related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor–targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

Autori: Toni K. Choueiri André P. Fay Daniel Y.C. Heng a ďalší

Prispievatelia: Toni K. Choueiri André P. Fay Daniel Y.C. Heng a ďalší

Zdroj: Cancer. 122:411-419

Predmety: Male, Antineoplastic Agents/administration & dosage, Indoles, Axitinib, Databases, Factual, Kaplan-Meier Estimate, Renal Cell/blood, Imidazoles/adverse effects, Niacinamide/analogs & derivatives, 0302 clinical medicine, Models, Kidney Neoplasms/blood, 80 and over, Phenylurea Compounds/adverse effects, Indazoles/adverse effects, Fatigue, Aged, 80 and over, Bevacizumab/administration & dosage, Kidney Neoplasms/drug therapy, Renal Cell/metabolism, Imidazoles, Indoles/administration & dosage, Statistical, Middle Aged, Kidney Neoplasms, 3. Good health, Molecular Targeted Therapy/adverse effects, Bevacizumab, Hand-Foot Syndrome/etiology, Fatigue/chemically induced, Indoles/adverse effects, Diarrhea/chemically induced, Female, Hand-Foot Syndrome, Diarrhea, Indazoles, Kidney Neoplasms/metabolism, Antineoplastic Agents, Bevacizumab/adverse effects, Drug Administration Schedule, Kidney Neoplasms/pathology, Databases, 03 medical and health sciences, Niacinamide/administration & dosage, Predictive Value of Tests, Niacinamide/adverse effects, Humans, Pyrimidines/administration & dosage, Carcinoma, Renal Cell, Factual, Aged, Pyrimidines/adverse effects, Pyrroles/administration & dosage, Carcinoma, Indazoles/administration & dosage, Phenylurea Compounds/administration & dosage, Renal Cell/secondary, Mucositis/chemically induced, Antineoplastic Agents/adverse effects, Renal Cell/drug therapy, Imidazoles/administration & dosage, Molecular Targeted Therapy/methods

Popis súboru: 411~419

Prístupová URL adresa: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.29773
https://pubmed.ncbi.nlm.nih.gov/26540173
https://yonsei.pure.elsevier.com/en/publications/risk-factors-and-model-for-predicting-toxicity-related-treatment-
http://onlinelibrary.wiley.com/doi/10.1002/cncr.29773/abstract
https://www.onlinelibrary.wiley.com/doi/10.1002/cncr.29773
https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.29773
https://europepmc.org/abstract/MED/26540173
http://www.ncbi.nlm.nih.gov/pubmed/26540173

Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane

Autori: Ji Soo Park Woo Ick Yang Beodeul Kang a ďalší

Prispievatelia: Ji Soo Park Woo Ick Yang Beodeul Kang a ďalší

Zdroj: Cancer Chemotherapy and Pharmacology. 74:799-808

Predmety: Bridged-Ring Compounds*/adverse effects, Breast Neoplasms*/mortality, Anthracyclines*/administration & dosage, Fluorouracil/adverse effects, Drug Screening Assays, Severity of Illness Index, Deoxycytidine, Breast cancer, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Anthracyclines, Local, Taxoids*/adverse effects, Hand-Foot Syndrome*/prevention & control, Neutropenia*/prevention & control, Middle Aged, Bridged-Ring Compounds*/administration & dosage, Breast Neoplasms*/drug therapy, Antineoplastic Agents/administration & dosage, 3. Good health, Fluorouracil/analogs & derivatives, Fluorouracil/administration & dosage, Treatment Outcome, Hand-Foot Syndrome*/physiopathology, Disease Progression, Metastatic, Female, Hand-Foot Syndrome, Fluorouracil, Drug, Recurrent, Bridged-Ring Compounds, Deoxycytidine/analogs & derivatives, Neutropenia, Anthracyclines*/adverse effects, Antineoplastic Agents, Breast Neoplasms, Disease-Free Survival, Drug Administration Schedule, Dose-Response Relationship, 03 medical and health sciences, Breast Neoplasms*/pathology, Chemotherapy, Humans, Deoxycytidine/administration & dosage, Capecitabine, Hand-Foot Syndrome*/etiology, Taxoids*/administration & dosage, Neoplasm Staging, Neutropenia*/physiopathology, Deoxycytidine/adverse effects, Dose-Response Relationship, Drug, Antineoplastic Agents/adverse effects, Antitumor, Neutropenia*/chemically induced, Gemcitabine, Neoplasm Recurrence, 13. Climate action, Republic of Korea/epidemiology, Drug Screening Assays, Antitumor, Neoplasm Recurrence, Local

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/25107569
https://europepmc.org/article/MED/25107569
https://ir.ymlib.yonsei.ac.kr/handle/22282913/99814
https://pubmed.ncbi.nlm.nih.gov/25107569/
https://link.springer.com/content/pdf/10.1007%2Fs00280-014-2551-4.pdf
https://link.springer.com/article/10.1007%2Fs00280-014-2551-4
https://yonsei.pure.elsevier.com/en/publications/phase-ii-gemcitabine-and-capecitabine-combination-therapy-in-recu

Safety and Pharmacokinetics of Sorafenib Combined With Capecitabine in Patients With Advanced Solid Tumors: Results of a Phase 1 Trial

Autori: Awada, Ahmad Gil, Thierry Whenham, Nicolas a ďalší

Zdroj: The Journal of Clinical Pharmacology. 51:1674-1684

Predmety: Adult, Diarrhea, Male, Niacinamide, 0301 basic medicine, Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- blood -- pharmacokinetics, Neoplasms -- drug therapy -- metabolism, Antineoplastic Agents, Deoxycytidine, Colonic Neoplasms -- drug therapy -- metabolism, Hand-Foot Syndrome -- etiology, 03 medical and health sciences, Antineoplastic Agents -- administration & dosage, 0302 clinical medicine, Benzenesulfonates -- administration & dosage, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Humans, Pyridines -- administration & dosage, Capecitabine, Fatigue, Aged, Fatigue -- chemically induced, Phenylurea Compounds, Benzenesulfonates, Deoxycytidine -- administration & dosage -- analogs & derivatives, Protein Kinase Inhibitors -- administration & dosage, Middle Aged, 3. Good health, Cancérologie, Area Under Curve, Colonic Neoplasms, Female, Hand-Foot Syndrome, Fluorouracil, Fluorouracil -- administration & dosage -- analogs & derivatives, Diarrhea -- chemically induced

Popis súboru: 1 full-text file(s): application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/21209247
http://onlinelibrary.wiley.com/doi/10.1177/0091270010386226/abstract
https://difusion.ulb.ac.be/vufind/Record/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/125348/Details
http://www.ncbi.nlm.nih.gov/pubmed/21209247
https://onlinelibrary.wiley.com/doi/abs/10.1177/0091270010386226
https://accp1.onlinelibrary.wiley.com/doi/abs/10.1177/0091270010386226

Efficacy and safety of regorafenib in the treatment of metastatic colorectal cancer:A systematic review

Autori: Røed Skårderud, Maria Polk, Anne Kjeldgaard Vistisen, Kirsten a ďalší

Zdroj: Røed Skårderud , M , Polk , A , Kjeldgaard Vistisen , K , Larsen , F O & Nielsen , D L 2018 , ' Efficacy and safety of regorafenib in the treatment of metastatic colorectal cancer : A systematic review ' , Cancer Treatment Reviews , vol. 62 , pp. 61-73 .

Témy: Antineoplastic Agents/therapeutic use, Clinical Trials, Phase III as Topic, Colorectal Neoplasms/drug therapy, Disease-Free Survival, Fatigue/chemically induced, Hand-Foot Syndrome/etiology, Humans, Hypertension/chemically induced, Neoplasm Metastasis, Phenylurea Compounds/therapeutic use, Proportional Hazards Models, Pyridines/therapeutic use, Survival Rate, article

URL: https://researchprofiles.ku.dk/da/publications/efficacy-and-safety-of-regorafenib-in-the-treatment-of-metastatic-colorectal-cancer(b56637e7-c066-4705-ace2-d22149ca3fe3).html
https://doi.org/10.1016/j.ctrv.2017.10.011